APA (7th ed.) Citation

Spiers, L., Gray, M., Lyon, P., Sivakumar, S., Bekkali, N., Scott, S., . . . Coussios, C. (2023). Clinical trial protocol for PanDox: A phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11228-z

Chicago Style (17th ed.) Citation

Spiers, Laura, et al. "Clinical Trial Protocol for PanDox: A Phase I Study of Targeted Chemotherapy Delivery to Non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused Ultrasound." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11228-z.

MLA (9th ed.) Citation

Spiers, Laura, et al. "Clinical Trial Protocol for PanDox: A Phase I Study of Targeted Chemotherapy Delivery to Non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused Ultrasound." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11228-z.